Brought to you by Applied Clinical Trials, The Clinical Data Disclosure and Transparency Resource Community is the go-to web destination for comprehensive data disclosure and transparency content.
Citeline Data Shows Higher Rate of Transparency Commitment
Sept. 10, 2014
TransCelerate Issues its CSR Redaction Approach for Data Sharing
Sept. 3, 2014
ECGCP Warns About Risks of Overprotecting Data
Aug. 1, 2014
ESMO's Concerns Over Data Protection and Research
July 25, 2014
Catching Up with Data Protection
July 21, 2014
EMA Delays Decision on Clinical Trial Data Until October
July 10, 2014
Pharma Improves Care by Sharing Clinical Trial Data
June 17, 2014
Privacy Analytics Launches Transparency Solution
June 18, 2014
Clinical Data Disclosure and Transparency
January 28-29, 2015 | Philadelphia, Pennsylvania
CBI’s successful inaugural event focusing on Clinical Data Disclosure and Transparency is back for its second year! This conference is the biggest of its kind and brings together high level executives to discuss and disseminate aspects of required data disclosure in a time of industry reform. Facing heightened pressure from the EMA, NIH, EFPIA, PhRMA and ICMJE to disclose clinical trial results and be transparent about all clinical trial data, this program focuses on the implications of and approaches being taken for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data.
Phase III THARROS Trial to Evaluate Impact of Breztri Aerosphere on Cardiopulmonary Outcomes in COPD
March 14th 2024THARROS trial investigators seek to provide first-of-its-kind evidence supporting a strategy of comprehensive cardiopulmonary risk reduction with a triple therapy in patients with chronic obstructive pulmonary disease.